VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Stock Comparison

GSK plc vs Mettler-Toledo International Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

GSK plc

GSK · London Stock Exchange

Market cap (USD)$89.3B
Gross margin (TTM)72.5%
Operating margin (TTM)22%
Net margin (TTM)17.5%
SectorHealthcare
IndustryDrug Manufacturers - General
CountryGB
Data as of2025-12-28
Moat score
62/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into GSK plc's moat claims, evidence, and risks.

View GSK analysis

Mettler-Toledo International Inc.

MTD · New York Stock Exchange

Market cap (USD)$28.1B
Gross margin (TTM)57.5%
Operating margin (TTM)27.8%
Net margin (TTM)21.6%
SectorHealthcare
IndustryMedical - Diagnostics & Research
CountryUS
Data as of2026-01-01
Moat score
73/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Mettler-Toledo International Inc.'s moat claims, evidence, and risks.

View MTD analysis

Comparison highlights

  • Moat score gap: Mettler-Toledo International Inc. leads (73 / 100 vs 62 / 100 for GSK plc).
  • Segment focus: GSK plc has 3 segments (37.6% in Specialty Medicines); Mettler-Toledo International Inc. has 3 segments (56% in Laboratory Products and Services).
  • Moat breadth: GSK plc has 4 moat types across 3 domains; Mettler-Toledo International Inc. has 5 across 3.

Primary market context

GSK plc

Specialty Medicines

Market

Branded specialty pharmaceuticals (HIV, oncology, immunology/respiratory)

Geography

Global

Customer

Hospitals, specialist physicians, payers

Role

Innovator & branded manufacturer

Revenue share

37.6%

Mettler-Toledo International Inc.

Laboratory Products and Services

Market

Laboratory precision weighing (balances/scales) and adjacent lab measurement & sample-prep instruments, plus related software and services

Geography

Global

Customer

Life science, chemical, academic, and testing laboratories (end-users) via direct sales and distributors

Role

Instrument OEM / software provider / service provider

Revenue share

56%

Side-by-side metrics

GSK plc
Mettler-Toledo International Inc.
Ticker / Exchange
GSK - London Stock Exchange
MTD - New York Stock Exchange
Market cap (USD)
$89.3B
$28.1B
Gross margin (TTM)
72.5%
57.5%
Operating margin (TTM)
22%
27.8%
Net margin (TTM)
17.5%
21.6%
Sector
Healthcare
Healthcare
Industry
Drug Manufacturers - General
Medical - Diagnostics & Research
HQ country
GB
US
Primary segment
Specialty Medicines
Laboratory Products and Services
Market structure
Oligopoly
Oligopoly
Market share
n/a
25%-30% (estimated)
HHI estimate
n/a
2,440
Pricing power
Strong
Strong
Moat score
62 / 100
73 / 100
Moat domains
Supply, Legal, Demand
Demand, Supply, Legal
Last update
2025-12-28
2026-01-01

Moat coverage

Shared moat types

Compliance AdvantageSwitching Costs General

GSK plc strengths

Capex Knowhow ScaleIP Choke Point

Mettler-Toledo International Inc. strengths

Brand TrustData Workflow LockinService Field Network

Segment mix

GSK plc segments

Full profile >

Vaccines

Oligopoly

29.1%

Specialty Medicines

Oligopoly

37.6%

General Medicines

Competitive

33.2%

Mettler-Toledo International Inc. segments

Full profile >

Laboratory Products and Services

Oligopoly

56%

Industrial Products and Services

Competitive

39%

Food Retailing Products and Services

Competitive

5%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.